BWM
BMY icon

Bulltick Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bulltick Wealth Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,600
Closed -$202K – 123
2022
Q2 		$202K Sell
2,600
-200
-7% -$15.2K 0.05% 120
2022
Q1 		$206K Buy
+2,800
New +$188K 0.05% 128

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bulltick Wealth Management's BMY Position: Q3 2022 in Review

Bulltick Wealth Management sold out of Bristol-Myers Squibb (BMY) in Q3 2022, closing a stake of 2,600 shares — an estimated $202K sold.

Bulltick Wealth Management first reported a position in BMY in Q1 2022 and held it in 2 quarters. The position peaked at $206K in Q1 2022. 2,470 funds tracked by Wall St. Rank hold BMY as of Q3 2022.

  • Bulltick Wealth Management reported no remaining Bristol-Myers Squibb position as of Q3 2022 after selling out during the quarter.
  • Bulltick Wealth Management sold 2,600 Bristol-Myers Squibb shares in Q3 2022, an estimated $202K.
  • Bulltick Wealth Management first reported a position in Bristol-Myers Squibb in Q1 2022 and held it in 2 quarters.
  • Bulltick Wealth Management's Bristol-Myers Squibb position peaked at $206K in Q1 2022.
  • 2,470 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2022.

Based on Bulltick Wealth Management's 13F filing for Q3 2022, filed 25 Apr 2024.